According to the website of the National Health Insurance Administration on March 3, the National Medical Insurance Administration, the Ministry of Finance, the National Health Commission, and the National Disease Control Administration issued a notice on further improving the protection of medical expenses for new crown patients.
Since the implementation of "Class B and B tubes" by the new coronavirus infection on January 2023, 1, the relevant departments have conscientiously implemented the requirements of the Notice on Optimizing the Medical Security for Treatment Costs of Patients with Novel Coronavirus Infection after the Implementation of "Class B and B Tubes", and have done a solid job in the protection of medical expenses for patients infected with new coronavirus infection, and the relevant policies have been implemented until March 8, 2023, helping the public smoothly pass the peak period of infection and strongly supporting the smooth transition of epidemic prevention and control. In order to implement the decision-making and deployment of the Party Central Committee and the State Council, and to do a good job in guaranteeing relevant medical expenses after April 3, the following notice is hereby issued on relevant matters:
1. Adjust the medical insurance reimbursement policy for new crown patients
Special insurance policies such as full coverage of inpatient expenses and special outpatient protection will be converted into conventional medical security policies, and the medical insurance reimbursement policy for eligible new crown medical expenses of insured patients will be the same as that of other Class B infectious diseases, and medical insurance departments at all levels shall settle the medical expenses of eligible new crown virus infection patients in a timely manner. After basic medical insurance and serious illness insurance are paid in accordance with regulations, where the personal burden is still heavy and meets the requirements for medical assistance, classified assistance shall be given in accordance with regulations.
2. Temporarily include the new crown treatment drugs outside the medical insurance list in eligible diagnosis and treatment plans into the scope of medical insurance payment
The National Health Insurance Administration has improved the price formation mechanism of new crown treatment drugs, and implemented categorical management according to the price level. New crown treatment drugs that are not included in the medical insurance catalogue in the national new crown virus infection diagnosis and treatment plan can be temporarily included in the payment scope of the medical insurance fund if they are listed in the category of "treatment costs are small from similar drugs in the medical insurance catalog" in the Notice on Improving the Price Formation Mechanism of New Crown Treatment Drugs and Implementing Categorical Management.
3. Continue to optimize medical insurance handling services
Medical insurance departments at all levels should continuously improve the handling workflow, improve the level of handling services, implement relevant policies such as long-distance medical settlement and long-term prescription medical insurance payment, and provide more high-quality, convenient and efficient medical insurance handling services for the insured people.
4. Strengthen publicity and interpretation of policy adjustments
Relevant departments should improve their political standing, deeply understand the profound connotation of achieving major and decisive victories in epidemic prevention and control and achieving a smooth transition, earnestly perform departmental responsibilities, strengthen coordination and cooperation, and jointly do a good job in publicizing and interpreting policy adjustments to ensure the smooth and orderly development of relevant work.
This notice will be implemented from April 2023, 4, calculated based on the time of patient admission or treatment, and the Notice on Optimizing the Medical Security Related Policies for Treatment Costs of Patients with Novel Coronavirus Infection after the Implementation of "Class B and B Tubes" (Medical Insurance Fa [1] No. 2023) will be suspended simultaneously, and relevant policies will be adjusted according to the development of the epidemic.